United States Biotechnology & Medical Research

Urovant Sciences Ltd (UROV)

Track

Ticker: UROV Exchange: NSM
Preparing chart...
Download chart Copy chart image Copy link Share to X Share


• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Buy signal Sell signal Earnings
No insider activity signals detected

Insider trades have not triggered unusual activity signals for this company.

Top insiders
Trades
Sumitomo Chemical Co., Ltd.
3 purchases — total 1,350,510 USD
Buy 19 Feb 2020
Value US$2,191,331.41 | Price 29.81 | Shares 54,091
Buy 19 Feb 2020
Value US$282,566.26 | Price 328.86 | Shares 24,041
Buy 19 Feb 2020
Value US$168,378.84 | Price 13.08 | Shares 12,873
Sale 27 Dec 2019
Value US$1,397,280.00 | Price 33.82 | Shares 30,515
Planned sale 9 Dec 2019
Value US$1,533,600.00 | Price 12.78 | Shares 120,000
Planned buy 19 Jun 2019
Value US$40,495.22 | Price 8.17 | Shares 4,957
Planned buy 19 Jun 2019
Value US$40,495.22 | Price 8.17 | Shares 4,957
Planned buy 19 Jun 2019
Value US$40,495.22 | Price 8.17 | Shares 4,957
Planned buy 19 Jun 2019
Value US$40,495.22 | Price 8.17 | Shares 4,957
Planned buy 19 Jun 2019
Value US$40,495.22 | Price 8.17 | Shares 4,957
Planned buy 19 Jun 2019
Value US$40,495.22 | Price 8.17 | Shares 4,957
Planned buy 19 Jun 2019
Value US$40,495.22 | Price 8.17 | Shares 4,957
Planned buy 19 Jun 2019
Value US$40,495.22 | Price 8.17 | Shares 4,957
Planned buy 18 Jun 2019
Value US$55,060.95 | Price 8.21 | Shares 6,706
Planned buy 18 Jun 2019
Value US$55,060.95 | Price 8.21 | Shares 6,706
Planned buy 18 Jun 2019
Value US$55,060.95 | Price 8.21 | Shares 6,706
Planned buy 18 Jun 2019
Value US$55,060.95 | Price 8.21 | Shares 6,706
Planned buy 18 Jun 2019
Value US$55,060.95 | Price 8.21 | Shares 6,706
Planned buy 18 Jun 2019
Value US$55,060.95 | Price 8.21 | Shares 6,706
Planned buy 18 Jun 2019
Value US$55,060.95 | Price 8.21 | Shares 6,706
Planned buy 18 Jun 2019
Value US$55,060.95 | Price 8.21 | Shares 6,706
Planned buy 17 Jun 2019
Value US$55,824.82 | Price 8.53 | Shares 6,541
Planned buy 17 Jun 2019
Value US$55,824.82 | Price 8.53 | Shares 6,541
Planned buy 17 Jun 2019
Value US$55,824.82 | Price 8.53 | Shares 6,541
Planned buy 17 Jun 2019
Value US$55,824.82 | Price 8.53 | Shares 6,541
Planned buy 17 Jun 2019
Value US$55,824.82 | Price 8.53 | Shares 6,541
Planned buy 17 Jun 2019
Value US$55,824.82 | Price 8.53 | Shares 6,541
Planned buy 17 Jun 2019
Value US$55,824.82 | Price 8.53 | Shares 6,541
Planned buy 17 Jun 2019
Value US$55,824.82 | Price 8.53 | Shares 6,541
Planned buy 14 Jun 2019
Value US$56,514.04 | Price 7.91 | Shares 7,144
Planned buy 14 Jun 2019
Value US$56,514.04 | Price 7.91 | Shares 7,144
Planned buy 14 Jun 2019
Value US$56,514.04 | Price 7.91 | Shares 7,144
Planned buy 14 Jun 2019
Value US$56,514.04 | Price 7.91 | Shares 7,144
Planned buy 14 Jun 2019
Value US$56,514.04 | Price 7.91 | Shares 7,144
Planned buy 14 Jun 2019
Value US$56,514.04 | Price 7.91 | Shares 7,144
Planned buy 14 Jun 2019
Value US$56,514.04 | Price 7.91 | Shares 7,144
Planned buy 14 Jun 2019
Value US$56,514.04 | Price 7.91 | Shares 7,144
Planned buy 13 Jun 2019
Value US$58,542.60 | Price 7.95 | Shares 7,367
Planned buy 13 Jun 2019
Value US$58,542.60 | Price 7.95 | Shares 7,367
Planned buy 13 Jun 2019
Value US$58,542.60 | Price 7.95 | Shares 7,367
Planned buy 13 Jun 2019
Value US$58,542.60 | Price 7.95 | Shares 7,367
Planned buy 13 Jun 2019
Value US$58,542.60 | Price 7.95 | Shares 7,367
Planned buy 13 Jun 2019
Value US$58,542.60 | Price 7.95 | Shares 7,367
Planned buy 13 Jun 2019
Value US$58,542.60 | Price 7.95 | Shares 7,367
Planned buy 13 Jun 2019
Value US$58,542.60 | Price 7.95 | Shares 7,367
Planned buy 12 Jun 2019
Value US$62,244.00 | Price 8.30 | Shares 7,500
Planned buy 12 Jun 2019
Value US$62,244.00 | Price 8.30 | Shares 7,500
Planned buy 12 Jun 2019
Value US$62,244.00 | Price 8.30 | Shares 7,500
Planned buy 12 Jun 2019
Value US$62,244.00 | Price 8.30 | Shares 7,500
Planned buy 12 Jun 2019
Value US$62,244.00 | Price 8.30 | Shares 7,500
Planned buy 12 Jun 2019
Value US$62,244.00 | Price 8.30 | Shares 7,500
Planned buy 12 Jun 2019
Value US$62,244.00 | Price 8.30 | Shares 7,500
Planned buy 12 Jun 2019
Value US$62,244.00 | Price 8.30 | Shares 7,500
Planned buy 11 Jun 2019
Value US$61,693.84 | Price 8.58 | Shares 7,189
Planned buy 11 Jun 2019
Value US$61,693.84 | Price 8.58 | Shares 7,189
Planned buy 11 Jun 2019
Value US$61,693.84 | Price 8.58 | Shares 7,189
Planned buy 11 Jun 2019
Value US$61,693.84 | Price 8.58 | Shares 7,189
Planned buy 11 Jun 2019
Value US$61,693.84 | Price 8.58 | Shares 7,189
Planned buy 11 Jun 2019
Value US$61,693.84 | Price 8.58 | Shares 7,189
Planned buy 11 Jun 2019
Value US$61,693.84 | Price 8.58 | Shares 7,189
Planned buy 11 Jun 2019
Value US$61,693.84 | Price 8.58 | Shares 7,189
Planned buy 10 Jun 2019
Value US$62,594.25 | Price 8.35 | Shares 7,500
Planned buy 10 Jun 2019
Value US$62,594.25 | Price 8.35 | Shares 7,500
Planned buy 10 Jun 2019
Value US$62,594.25 | Price 8.35 | Shares 7,500
Planned buy 10 Jun 2019
Value US$62,594.25 | Price 8.35 | Shares 7,500
Planned buy 10 Jun 2019
Value US$62,594.25 | Price 8.35 | Shares 7,500
Planned buy 10 Jun 2019
Value US$62,594.25 | Price 8.35 | Shares 7,500
Planned buy 10 Jun 2019
Value US$62,594.25 | Price 8.35 | Shares 7,500
Planned buy 10 Jun 2019
Value US$62,594.25 | Price 8.35 | Shares 7,500
Planned buy 7 Jun 2019
Value US$52,959.28 | Price 7.97 | Shares 6,649
Planned buy 7 Jun 2019
Value US$52,959.28 | Price 7.97 | Shares 6,649
Planned buy 7 Jun 2019
Value US$52,959.28 | Price 7.97 | Shares 6,649
Planned buy 7 Jun 2019
Value US$52,959.28 | Price 7.97 | Shares 6,649
Planned buy 7 Jun 2019
Value US$52,959.28 | Price 7.97 | Shares 6,649
Planned buy 7 Jun 2019
Value US$52,959.28 | Price 7.97 | Shares 6,649
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Notification date Transaction date B/S Transaction type Insider and/or position Nb. shares
Price
Value 		Number of shares Price Value Details
2020-02-21 2020-02-19 B Purchase
Sumitomo Chemical Co., Ltd.
54,091 -43.9%
29.81
US$2,191,331 		54,091 -43.9% 29.81 US$2,191,331
2020-02-21 2020-02-19 B Purchase
Sumitomo Chemical Co., Ltd.
24,041 -44.0%
328.86
US$282,566 		24,041 -44.0% 328.86 US$282,566
2020-02-21 2020-02-19 B Purchase
Sumitomo Chemical Co., Ltd.
52,087 -49.9%
89.96
US$4,634,471 		52,087 -49.9% 89.96 US$4,634,471
2019-12-31 2019-12-27 S Sale Roivant Sciences Ltd. Large shareholder
22,860,013
0.00
US$0 		22,860,013 0.00 US$0
2019-12-11 2019-12-09 PlS Planned sale Katkin Keith

PEO;CEO/Urovant Sciences, Inc.

Executive Director
120,000 -100.0%
12.78
US$1,533,600 		120,000 -100.0% 12.78 US$1,533,600
2019-06-19 2019-06-19 PP Planned purchase
QVT Associates GP LLC
Large shareholder
4,957 +0.0%
8.17
US$40,495 		4,957 +0.0% 8.17 US$40,495
2019-06-19 2019-06-19 PP Planned purchase
2.0
VIKING GLOBAL PERFORMANCE LLC
Large shareholder
4,957 +0.0%
8.17
US$40,495 		4,957 +0.0% 8.17 US$40,495
2019-06-19 2019-06-19 PP Planned purchase
1.5
Machado Patrick
Large shareholder
4,957 +0.0%
8.17
US$40,495 		4,957 +0.0% 8.17 US$40,495
2019-06-19 2019-06-19 PP Planned purchase
3.2
VIKING GLOBAL INVESTORS LP
Large shareholder
4,957 +0.0%
8.17
US$40,495 		4,957 +0.0% 8.17 US$40,495
2019-06-19 2019-06-19 PP Planned purchase
2.5
Lo Andrew
Large shareholder
4,957 +0.0%
8.17
US$40,495 		4,957 +0.0% 8.17 US$40,495
2019-06-19 2019-06-19 PP Planned purchase
Dexxon Holdings Ltd.
Large shareholder
4,957 +0.0%
8.17
US$40,495 		4,957 +0.0% 8.17 US$40,495
2019-06-19 2019-06-19 PP Planned purchase
3.2
SVF Investments (UK) Ltd
Large shareholder
4,957 +0.0%
8.17
US$40,495 		4,957 +0.0% 8.17 US$40,495
2019-06-19 2019-06-19 PP Planned purchase
1.9
Roivant Sciences Ltd.
Large shareholder
4,957 +0.0%
8.17
US$40,495 		4,957 +0.0% 8.17 US$40,495
2019-06-19 2019-06-18 PP Planned purchase
QVT Associates GP LLC
Large shareholder
6,706 +0.0%
8.21
US$55,061 		6,706 +0.0% 8.21 US$55,061
2019-06-19 2019-06-18 PP Planned purchase
2.0
VIKING GLOBAL PERFORMANCE LLC
Large shareholder
6,706 +0.0%
8.21
US$55,061 		6,706 +0.0% 8.21 US$55,061
2019-06-19 2019-06-18 PP Planned purchase
1.5
Machado Patrick
Large shareholder
6,706 +0.0%
8.21
US$55,061 		6,706 +0.0% 8.21 US$55,061
2019-06-19 2019-06-18 PP Planned purchase
3.2
VIKING GLOBAL INVESTORS LP
Large shareholder
6,706 +0.0%
8.21
US$55,061 		6,706 +0.0% 8.21 US$55,061
2019-06-19 2019-06-18 PP Planned purchase
2.5
Lo Andrew
Large shareholder
6,706 +0.0%
8.21
US$55,061 		6,706 +0.0% 8.21 US$55,061
2019-06-19 2019-06-18 PP Planned purchase
Dexxon Holdings Ltd.
Large shareholder
6,706 +0.0%
8.21
US$55,061 		6,706 +0.0% 8.21 US$55,061
2019-06-19 2019-06-18 PP Planned purchase
3.2
SVF Investments (UK) Ltd
Large shareholder
6,706 +0.0%
8.21
US$55,061 		6,706 +0.0% 8.21 US$55,061
2019-06-19 2019-06-18 PP Planned purchase
1.9
Roivant Sciences Ltd.
Large shareholder
6,706 +0.0%
8.21
US$55,061 		6,706 +0.0% 8.21 US$55,061
2019-06-19 2019-06-17 PP Planned purchase
QVT Associates GP LLC
Large shareholder
6,541 +0.0%
8.53
US$55,825 		6,541 +0.0% 8.53 US$55,825
2019-06-19 2019-06-17 PP Planned purchase
2.0
VIKING GLOBAL PERFORMANCE LLC
Large shareholder
6,541 +0.0%
8.53
US$55,825 		6,541 +0.0% 8.53 US$55,825
2019-06-19 2019-06-17 PP Planned purchase
1.5
Machado Patrick
Large shareholder
6,541 +0.0%
8.53
US$55,825 		6,541 +0.0% 8.53 US$55,825
2019-06-19 2019-06-17 PP Planned purchase
3.2
VIKING GLOBAL INVESTORS LP
Large shareholder
6,541 +0.0%
8.53
US$55,825 		6,541 +0.0% 8.53 US$55,825
2019-06-19 2019-06-17 PP Planned purchase
2.5
Lo Andrew
Large shareholder
6,541 +0.0%
8.53
US$55,825 		6,541 +0.0% 8.53 US$55,825
2019-06-19 2019-06-17 PP Planned purchase
Dexxon Holdings Ltd.
Large shareholder
6,541 +0.0%
8.53
US$55,825 		6,541 +0.0% 8.53 US$55,825
2019-06-19 2019-06-17 PP Planned purchase
3.2
SVF Investments (UK) Ltd
Large shareholder
6,541 +0.0%
8.53
US$55,825 		6,541 +0.0% 8.53 US$55,825
2019-06-19 2019-06-17 PP Planned purchase
1.9
Roivant Sciences Ltd.
Large shareholder
6,541 +0.0%
8.53
US$55,825 		6,541 +0.0% 8.53 US$55,825
2019-06-14 2019-06-14 PP Planned purchase
3.2
VIKING GLOBAL INVESTORS LP
Large shareholder
7,144 +0.0%
7.91
US$56,514 		7,144 +0.0% 7.91 US$56,514
2019-06-14 2019-06-14 PP Planned purchase
1.9
Roivant Sciences Ltd.
Large shareholder
7,144 +0.0%
7.91
US$56,514 		7,144 +0.0% 7.91 US$56,514
2019-06-14 2019-06-14 PP Planned purchase
Dexxon Holdings Ltd.
Large shareholder
7,144 +0.0%
7.91
US$56,514 		7,144 +0.0% 7.91 US$56,514
2019-06-14 2019-06-14 PP Planned purchase
3.2
SVF Investments (UK) Ltd
Large shareholder
7,144 +0.0%
7.91
US$56,514 		7,144 +0.0% 7.91 US$56,514
2019-06-14 2019-06-14 PP Planned purchase
2.5
Lo Andrew
Large shareholder
7,144 +0.0%
7.91
US$56,514 		7,144 +0.0% 7.91 US$56,514
2019-06-14 2019-06-14 PP Planned purchase
QVT Associates GP LLC
Large shareholder
7,144 +0.0%
7.91
US$56,514 		7,144 +0.0% 7.91 US$56,514
2019-06-14 2019-06-14 PP Planned purchase
2.0
VIKING GLOBAL PERFORMANCE LLC
Large shareholder
7,144 +0.0%
7.91
US$56,514 		7,144 +0.0% 7.91 US$56,514
2019-06-14 2019-06-14 PP Planned purchase
1.5
Machado Patrick
Large shareholder
7,144 +0.0%
7.91
US$56,514 		7,144 +0.0% 7.91 US$56,514
2019-06-14 2019-06-13 PP Planned purchase
3.2
VIKING GLOBAL INVESTORS LP
Large shareholder
7,367 +0.0%
7.95
US$58,543 		7,367 +0.0% 7.95 US$58,543
2019-06-14 2019-06-13 PP Planned purchase
1.9
Roivant Sciences Ltd.
Large shareholder
7,367 +0.0%
7.95
US$58,543 		7,367 +0.0% 7.95 US$58,543
2019-06-14 2019-06-13 PP Planned purchase
Dexxon Holdings Ltd.
Large shareholder
7,367 +0.0%
7.95
US$58,543 		7,367 +0.0% 7.95 US$58,543
2019-06-14 2019-06-13 PP Planned purchase
3.2
SVF Investments (UK) Ltd
Large shareholder
7,367 +0.0%
7.95
US$58,543 		7,367 +0.0% 7.95 US$58,543
2019-06-14 2019-06-13 PP Planned purchase
2.5
Lo Andrew
Large shareholder
7,367 +0.0%
7.95
US$58,543 		7,367 +0.0% 7.95 US$58,543
2019-06-14 2019-06-13 PP Planned purchase
QVT Associates GP LLC
Large shareholder
7,367 +0.0%
7.95
US$58,543 		7,367 +0.0% 7.95 US$58,543
2019-06-14 2019-06-13 PP Planned purchase
2.0
VIKING GLOBAL PERFORMANCE LLC
Large shareholder
7,367 +0.0%
7.95
US$58,543 		7,367 +0.0% 7.95 US$58,543
2019-06-14 2019-06-13 PP Planned purchase
1.5
Machado Patrick
Large shareholder
7,367 +0.0%
7.95
US$58,543 		7,367 +0.0% 7.95 US$58,543
2019-06-14 2019-06-12 PP Planned purchase
3.2
VIKING GLOBAL INVESTORS LP
Large shareholder
7,500 +0.0%
8.30
US$62,244 		7,500 +0.0% 8.30 US$62,244
2019-06-14 2019-06-12 PP Planned purchase
1.9
Roivant Sciences Ltd.
Large shareholder
7,500 +0.0%
8.30
US$62,244 		7,500 +0.0% 8.30 US$62,244
2019-06-14 2019-06-12 PP Planned purchase
Dexxon Holdings Ltd.
Large shareholder
7,500 +0.0%
8.30
US$62,244 		7,500 +0.0% 8.30 US$62,244
2019-06-14 2019-06-12 PP Planned purchase
3.2
SVF Investments (UK) Ltd
Large shareholder
7,500 +0.0%
8.30
US$62,244 		7,500 +0.0% 8.30 US$62,244
2019-06-14 2019-06-12 PP Planned purchase
2.5
Lo Andrew
Large shareholder
7,500 +0.0%
8.30
US$62,244 		7,500 +0.0% 8.30 US$62,244
2019-06-14 2019-06-12 PP Planned purchase
QVT Associates GP LLC
Large shareholder
7,500 +0.0%
8.30
US$62,244 		7,500 +0.0% 8.30 US$62,244
2019-06-14 2019-06-12 PP Planned purchase
2.0
VIKING GLOBAL PERFORMANCE LLC
Large shareholder
7,500 +0.0%
8.30
US$62,244 		7,500 +0.0% 8.30 US$62,244
2019-06-14 2019-06-12 PP Planned purchase
1.5
Machado Patrick
Large shareholder
7,500 +0.0%
8.30
US$62,244 		7,500 +0.0% 8.30 US$62,244
2019-06-11 2019-06-11 PP Planned purchase
2.0
VIKING GLOBAL PERFORMANCE LLC
Large shareholder
7,189 +0.0%
8.58
US$61,694 		7,189 +0.0% 8.58 US$61,694
2019-06-11 2019-06-11 PP Planned purchase
1.9
Roivant Sciences Ltd.
Large shareholder
7,189 +0.0%
8.58
US$61,694 		7,189 +0.0% 8.58 US$61,694
2019-06-11 2019-06-11 PP Planned purchase
QVT Associates GP LLC
Large shareholder
7,189 +0.0%
8.58
US$61,694 		7,189 +0.0% 8.58 US$61,694
2019-06-11 2019-06-11 PP Planned purchase
1.5
Machado Patrick
Large shareholder
7,189 +0.0%
8.58
US$61,694 		7,189 +0.0% 8.58 US$61,694
2019-06-11 2019-06-11 PP Planned purchase
3.2
VIKING GLOBAL INVESTORS LP
Large shareholder
7,189 +0.0%
8.58
US$61,694 		7,189 +0.0% 8.58 US$61,694
2019-06-11 2019-06-11 PP Planned purchase
3.2
SVF Investments (UK) Ltd
Large shareholder
7,189 +0.0%
8.58
US$61,694 		7,189 +0.0% 8.58 US$61,694
2019-06-11 2019-06-11 PP Planned purchase
2.5
Lo Andrew
Large shareholder
7,189 +0.0%
8.58
US$61,694 		7,189 +0.0% 8.58 US$61,694
2019-06-11 2019-06-11 PP Planned purchase
Dexxon Holdings Ltd.
Large shareholder
7,189 +0.0%
8.58
US$61,694 		7,189 +0.0% 8.58 US$61,694
2019-06-11 2019-06-10 PP Planned purchase
2.0
VIKING GLOBAL PERFORMANCE LLC
Large shareholder
7,500 +0.0%
8.35
US$62,594 		7,500 +0.0% 8.35 US$62,594
2019-06-11 2019-06-10 PP Planned purchase
1.9
Roivant Sciences Ltd.
Large shareholder
7,500 +0.0%
8.35
US$62,594 		7,500 +0.0% 8.35 US$62,594
2019-06-11 2019-06-10 PP Planned purchase
QVT Associates GP LLC
Large shareholder
7,500 +0.0%
8.35
US$62,594 		7,500 +0.0% 8.35 US$62,594
2019-06-11 2019-06-10 PP Planned purchase
1.5
Machado Patrick
Large shareholder
7,500 +0.0%
8.35
US$62,594 		7,500 +0.0% 8.35 US$62,594
2019-06-11 2019-06-10 PP Planned purchase
3.2
VIKING GLOBAL INVESTORS LP
Large shareholder
7,500 +0.0%
8.35
US$62,594 		7,500 +0.0% 8.35 US$62,594
2019-06-11 2019-06-10 PP Planned purchase
3.2
SVF Investments (UK) Ltd
Large shareholder
7,500 +0.0%
8.35
US$62,594 		7,500 +0.0% 8.35 US$62,594
2019-06-11 2019-06-10 PP Planned purchase
2.5
Lo Andrew
Large shareholder
7,500 +0.0%
8.35
US$62,594 		7,500 +0.0% 8.35 US$62,594
2019-06-11 2019-06-10 PP Planned purchase
Dexxon Holdings Ltd.
Large shareholder
7,500 +0.0%
8.35
US$62,594 		7,500 +0.0% 8.35 US$62,594
2019-06-11 2019-06-07 PP Planned purchase
2.0
VIKING GLOBAL PERFORMANCE LLC
Large shareholder
6,649 +0.0%
7.97
US$52,959 		6,649 +0.0% 7.97 US$52,959
2019-06-11 2019-06-07 PP Planned purchase
1.9
Roivant Sciences Ltd.
Large shareholder
6,649 +0.0%
7.97
US$52,959 		6,649 +0.0% 7.97 US$52,959
2019-06-11 2019-06-07 PP Planned purchase
QVT Associates GP LLC
Large shareholder
6,649 +0.0%
7.97
US$52,959 		6,649 +0.0% 7.97 US$52,959
2019-06-11 2019-06-07 PP Planned purchase
1.5
Machado Patrick
Large shareholder
6,649 +0.0%
7.97
US$52,959 		6,649 +0.0% 7.97 US$52,959
2019-06-11 2019-06-07 PP Planned purchase
3.2
VIKING GLOBAL INVESTORS LP
Large shareholder
6,649 +0.0%
7.97
US$52,959 		6,649 +0.0% 7.97 US$52,959
2019-06-11 2019-06-07 PP Planned purchase
3.2
SVF Investments (UK) Ltd
Large shareholder
6,649 +0.0%
7.97
US$52,959 		6,649 +0.0% 7.97 US$52,959
Explore more

More insider trading research around Urovant Sciences Ltd

More insider trades in United States
Similar Healthcare companies with insider activity
More Pharmaceuticals & Medical Research companies with insider activity
More Biotechnology & Medical Research companies with insider activity
Insider trading in North America